223 — Elife Holdings Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Elife Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
R2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 276 | 153 | 239 | 184 | 178 |
| Cost of Revenue | |||||
| Gross Profit | 9.46 | 7.85 | 1.87 | 31.9 | 15.9 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 302 | 195 | 261 | 207 | 231 |
| Operating Profit | -26.3 | -42.4 | -22.5 | -23.4 | -53.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -28 | -44.9 | -22.8 | -23.8 | -53.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -29.7 | -46.6 | -22.9 | -29 | -55.7 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -26.4 | -40.8 | -21.7 | -32 | -97.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -26.4 | -40.8 | -21.7 | -32 | -97.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.043 | -0.059 | -0.027 | -0.032 | -0.044 |